These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 7553639

  • 1. Taxol induction of p21WAF1 and p53 requires c-raf-1.
    Blagosklonny MV, Schulte TW, Nguyen P, Mimnaugh EG, Trepel J, Neckers L.
    Cancer Res; 1995 Oct 15; 55(20):4623-6. PubMed ID: 7553639
    [Abstract] [Full Text] [Related]

  • 2. Mechanisms of Taxol-induced cell death are concentration dependent.
    Torres K, Horwitz SB.
    Cancer Res; 1998 Aug 15; 58(16):3620-6. PubMed ID: 9721870
    [Abstract] [Full Text] [Related]

  • 3. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R.
    Int J Oncol; 2004 Mar 15; 24(3):591-608. PubMed ID: 14767544
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The phosphatidylinositol 3-kinase/AKT signal transduction pathway plays a critical role in the expression of p21WAF1/CIP1/SDI1 induced by cisplatin and paclitaxel.
    Mitsuuchi Y, Johnson SW, Selvakumaran M, Williams SJ, Hamilton TC, Testa JR.
    Cancer Res; 2000 Oct 01; 60(19):5390-4. PubMed ID: 11034077
    [Abstract] [Full Text] [Related]

  • 6. Serine protease inhibitor TPCK prevents Taxol-induced cell death and blocks c-Raf-1 and Bcl-2 phosphorylation in human breast carcinoma cells.
    Huang Y, Sheikh MS, Fornace AJ, Holbrook NJ.
    Oncogene; 1999 Jun 10; 18(23):3431-9. PubMed ID: 10376521
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Dexamethasone-mediated protection from drug cytotoxicity: association with p21WAF1/CIP1 protein accumulation?
    Naumann U, Durka S, Weller M.
    Oncogene; 1998 Sep 24; 17(12):1567-75. PubMed ID: 9794234
    [Abstract] [Full Text] [Related]

  • 9. Role of p53 in aziridinylbenzoquinone-induced p21waf1 expression.
    Wu RC, Hohenstein A, Park JM, Qiu X, Mueller S, Cadenas E, Schönthal AH.
    Oncogene; 1998 Jul 23; 17(3):357-65. PubMed ID: 9690517
    [Abstract] [Full Text] [Related]

  • 10. Inactivation of wild-type p53 by a dominant negative mutant renders MCF-7 cells resistant to tubulin-binding agent cytotoxicity.
    Galmarini CM, Falette N, Tabone E, Levrat C, Britten R, Voorzanger-Rousselot N, Roesch-Gateau O, Vanier-Viornery A, Puisieux A, Dumontet C.
    Br J Cancer; 2001 Sep 14; 85(6):902-8. PubMed ID: 11556844
    [Abstract] [Full Text] [Related]

  • 11. Induction of apoptosis by the p53-273L (Arg --> Leu) mutant in HSC3 cells without transactivation of p21Waf1/Cip1/Sdi1 and bax.
    Kaneuchi M, Yamashita T, Shindoh M, Segawa K, Takahashi S, Furuta I, Fujimoto S, Fujinaga K.
    Mol Carcinog; 1999 Sep 14; 26(1):44-52. PubMed ID: 10487521
    [Abstract] [Full Text] [Related]

  • 12. Expression of p53 in cisplatin-resistant ovarian cancer cell lines: modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV).
    Hagopian GS, Mills GB, Khokhar AR, Bast RC, Siddik ZH.
    Clin Cancer Res; 1999 Mar 14; 5(3):655-63. PubMed ID: 10100719
    [Abstract] [Full Text] [Related]

  • 13. Reduced expression of p53 and p21WAF1/CIP1 sensitizes human breast cancer cells to paclitaxel and its combination with 5-fluorouracil.
    Johnson KR, Fan W.
    Anticancer Res; 2002 Mar 14; 22(6A):3197-204. PubMed ID: 12530065
    [Abstract] [Full Text] [Related]

  • 14. Bifunctional effects of a protein kinase inhibitor (H-7) on heat-induced p53-dependent WAF1 accumulation.
    Wang X, Takahashi A, Ohnishi K, Matsumoto H, Suda K, Ohnishi T.
    Exp Cell Res; 1997 Nov 25; 237(1):186-91. PubMed ID: 9417881
    [Abstract] [Full Text] [Related]

  • 15. p21WAF1 expression by an activator of protein kinase C is regulated mainly at the post-transcriptional level in cells lacking p53: important role of RNA stabilization.
    Akashi M, Osawa Y, Koeffler HP, Hachiya M.
    Biochem J; 1999 Feb 01; 337 ( Pt 3)(Pt 3):607-16. PubMed ID: 9895308
    [Abstract] [Full Text] [Related]

  • 16. Polyamine analogue induction of the p53-p21WAF1/CIP1-Rb pathway and G1 arrest in human melanoma cells.
    Kramer DL, Vujcic S, Diegelman P, Alderfer J, Miller JT, Black JD, Bergeron RJ, Porter CW.
    Cancer Res; 1999 Mar 15; 59(6):1278-86. PubMed ID: 10096560
    [Abstract] [Full Text] [Related]

  • 17. Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway.
    Blagosklonny MV, Schulte T, Nguyen P, Trepel J, Neckers LM.
    Cancer Res; 1996 Apr 15; 56(8):1851-4. PubMed ID: 8620503
    [Abstract] [Full Text] [Related]

  • 18. Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53.
    Bacus SS, Gudkov AV, Lowe M, Lyass L, Yung Y, Komarov AP, Keyomarsi K, Yarden Y, Seger R.
    Oncogene; 2001 Jan 11; 20(2):147-55. PubMed ID: 11313944
    [Abstract] [Full Text] [Related]

  • 19. Destabilization of Raf-1 by geldanamycin leads to disruption of the Raf-1-MEK-mitogen-activated protein kinase signalling pathway.
    Schulte TW, Blagosklonny MV, Romanova L, Mushinski JF, Monia BP, Johnston JF, Nguyen P, Trepel J, Neckers LM.
    Mol Cell Biol; 1996 Oct 11; 16(10):5839-45. PubMed ID: 8816498
    [Abstract] [Full Text] [Related]

  • 20. Alterations in the growth factor signal transduction pathways and modulators of the cell cycle in endocervical cells from macaques exposed to TCDD.
    Enan E, El-Sabeawy F, Scott M, Overstreet J, Lasley B.
    Toxicol Appl Pharmacol; 1998 Aug 11; 151(2):283-93. PubMed ID: 9707505
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.